Two peptide modifications of serum albumin in atherosclerotic patients' HSA were similar to those generated by treatment of HSA with MDA in vitro.
SUMMARY
Human dendritic cells were differentiated from blood monocytes and treated with malondialdehyde (MDA) conjugated with human serum albumin (HSA). Autologous T cells from human plaques or blood were cocultured with the pre-treated dendritic cells or treated directly. MDA modifications were studied by mass spectrometry. MDA-HSA induced a pro-inflammatory DC-mediated T-cell activation and also a strong direct effect on T cells, inhibited by an inhibitor of oxidative stress and antibodies against MDA. Atherogenic heat shock protein-60 was strongly induced in T cells activated by MDA-HSA. Two peptide modifications in atherosclerotic patients' HSA were similar to those present in in vitro MDA-modified HSA. signaling (11, 12) .
In humans, an association between the CD8 þ subset of T cells and CVD has been reported (13) . The DCs and T cells co-localized in plaques may play a role in local immune reactions within lesions (14) . DCs may be of major importance during different stages of the development of atherosclerosis in humans (15) (16) (17) . We reported recently that production of antibodies against both PC and MDA conjugated with an albumin is dependent on T cells in humans. Moreover, these antibodies together strongly and negatively correlated with atherosclerosis and vulnerable plaques in systemic lupus erythematosus (where the risk of CVD is exceedingly high) and also with the risk of CVD in a general population (18, 19) .
Heat shock protein (HSP) 60 may be involved in activation of T cells by OxLDL, as well as the atherosclerotic immunity in general (20), and more specifically in T-cell activation (6, 21) . We report that MDA-human serum albumin (HSA)
activates DCs and T cells, the latter even directly, and that this effect is inhibited by anti-MDA antibodies.
The implications of these findings are discussed. Cells were isolated from atherosclerotic plaques as described earlier (22) . In brief, the plaques were first dissected into small pieces, which were then To stop the reaction, 1 mol/l H 2 SO 4 was added and absorption at 450-nm wavelength (with 690 nm as reference) determined.
METHODS
Rahman et al.
Malondialdehyde Activates Plaque T Cells Hypersep plate (Thermo Scientific), dried using a Speedvac, and re-suspended in 25 ml 2% Acetonitrile/ 0.1% formic acid.
LIQUID CHROMATOGRAPHY-MS/MS ANALYSIS.
Peptides were separated on a 50-cm Easy C18 chromatography column connected to an nLC1000 system (Thermo Fisher Scientific). The peptides were loaded onto this column at a flow rate of 1000 nl/min, and then eluted at 300 nl/min flow rate for 120 min with linear gradient from 4% to 26% AcN in 0.1% formic Rahman et al.
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INDUCTION OF HSP60
. MDA-HSA induced HSP60 in both T-cells ( Figure 3A) and DCs ( Figure 3B ) from healthy donors as well as plaque T cells ( Figure 3C ). Rahman et al.
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Rahman et al. (not shown).
MS ANALYSIS. After treating HSA in vitro, 31 peptides could be identified ( Table 1 ) (see Supplemental ROS ¼ reactive oxygen species; other abbreviations as in Figure 1 .
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Figure 5 for a representation of MS tracings). In the HSA of atherosclerotic patients, there were 9 MDAmodified peptides ( Table 2) , 2 of which were similar to those obtained in in vitro modification (set in boldface in Tables 1 and 2) .
DISCUSSION
OxLDL has a complex structure, the different parts of which might play varying roles in immune activation.
Apparently, mice and humans differ in this respect;
LDL in a murine model activates T cells.
We have shown that OxLDL activates T cells in humans (4, 5) , which is a finding confirmed by others (7) that has recently been further developed (6, 21) .
Therefore, we chose here to study T cells isolated directly from human atherosclerotic plaques in relation to DCs from the same individuals, that is, an ex vivo human model similar to that described previously (6,21).
We report for the first time that MDA, conjugated with autologous human albumin, activates T cells, including those isolated from plaques, by both direct and, to some extent, indirect mechanisms via DCs. As expected, albumin itself has no effect.
MDA-HSA induced a pro-inflammatory activation MAPK ¼ mitogen-activated protein kinase; TLR ¼ Toll-like receptor; other abbreviations as in Figure 1 .
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Because MDA is exposed extensively in athero- and in other cases they have provided to be risk markers (2, 19) .
We focused on the phospholipid portion of OxLDL, where compounds such as PC and MDA are typically Two peptides from patients' plasma had similar modification as in vitro modification (bold).
MDA ¼ malondialdehyde; HSA ¼ human serum albumin.
Malondialdehyde Activates Plaque T Cells A U G U S T 2 0 1 9 : 4 8 0 -9 4 generated and exposed, the latter binding especially readily to proteins.
Both anti-PC and anti-MDA immunoglobulin M (IgM) antibodies are markers of protection, even when exposed on compounds other than those related to oxLDL such as albumin (2, 18) . Two peptides from patients' plasma had similar modification as in vitro modification (bold).
Abbreviations as in Table 1 . In addition, macrophages of the M1 and M2 phenotypes have been divided into further subtypes, and several stimuli have been described that could promote such processes. In general, the M1 subtype is believed to be atherogenic, and in light of its proinflammatory features, it may also promote CVD.
M1 is associated with
Whereas the M1 phenotype is known to be induced by 
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